Gallbladder and Biliary Tract Disease News

• Diabetes, Fatty Liver Disease, Ultraprocessed Foods Linked Metabolic-associated fatty liver disease has become the most common cause of chronic liver disease. It is estimated that cases will increase by 56% over the next 10 years.
  Medscape Medical News, June 08, 2023
• NASH Drug Shown to Reduce Liver Fat by 65% in Some Patients Akero Therapeutics said on Monday data from a mid-stage study showed its experimental therapy reduced liver fat by 65% in certain patients with a type of fatty liver disease called nonalcoholic steatohepatitis.
  Reuters Health Information, June 05, 2023
• Intercept Tumbles on Concerns Over Prospects of Fatty Liver Disease Drug Shares of Intercept fell about 16% on Monday over concerns about the prospects of the company's drug to treat a type of fatty liver disease after the regulator's advisory panel voted to defer an accelerated approval.
  Reuters Health Information, May 22, 2023
• Hepion's NASH Drug Meets Main Goal in Midstage Trial Hepion Pharmaceuticals said on Monday its treatment met the main goal of improving liver function in patients with a type of fatty liver disease in a midstage study trial.
  Reuters Health Information, May 22, 2023
• ChatGPT Bot Flunks Gastroenterology Exam The AI language-processing model scored below the minimum passing grade of 70% on a self-assessment test and is not recommended for medical education.
  Medscape Medical News, May 23, 2023
• FDA Staff Flag 'Serious' Safety Risks for NASH Treatment The health regulator's staff reviewers on Wednesday raised a string of concerns with Intercept's treatment for a type of fatty liver disease, sending the drugmaker's shares plunging 22%.
  Reuters Health Information, May 17, 2023
• DDW 2023 Analysis: 40% of Info About Cirrhosis on TikTok Is Incorrect Study presented at DDW finds that patient-derived sources are usually trustworthy, but promotional sources are often misleading.
  MDedge News, May 18, 2023
• Guidelines for Kids With Obesity The goal was to "help patients make changes in lifestyle, behaviors, or environment in a sustainable way and also to involve families in decision-making at every step of the way."
  WebMD Health News, May 17, 2023
• Viking Therapeutics's NASH Drug Succeeds in Midstage Trial Viking Therapeutics said on Tuesday its experimental drug met the main goal of a midstage trial to treat patients with a type of fatty liver disease, sending its shares about 6% higher in early trade.
  Reuters Health Information, May 16, 2023
• DDW 2023 Most Crohn's and Liver Disease Info on TikTok Is Accurate How does TikTok stack up on health information? Medical experts watched thousands of posts in two research projects to find out.
  WebMD Health News, May 16, 2023
• Statins Appear to Guard Against Liver Disease Progression A large Swedish cohort study finds a significant protective association between statin use and liver disease progression in adults with non-cirrhotic chronic liver disease.
  Medscape Medical News, May 12, 2023
• European Associations Review Dietary Therapies for Obesity A new statement responds to the need to confront a problem with "epidemic overtones" that continues to grow across Europe, according to its authors.
  Medscape Medical News, April 28, 2023
• Liver Disease Does Not Worsen IVF Outcomes In vitro fertilization treatment and pregnancy outcomes do not differ significantly between women with and those without liver disease who undergo treatment with assisted reproductive technology, a study finds.
  Medscape Medical News, April 24, 2023
• Harnessing ChatGPT to Improve Liver Disease Outcomes ChatGPT may be a useful adjunctive informational tool for patients with cirrhosis or liver cancer and their clinicians by generating easy-to-understand information about the disease.
  Medscape Medical News, April 13, 2023
• Update Addresses Role of EUS-GBD in Acute Cholecystitis Selecting the optimal drainage method depends on patient characteristics.
  Medscape Medical News, April 07, 2023
• New Trials in Non-CRC GI Cancers: Could Your Patient Benefit? Perhaps one of your patients could benefit from joining a clinical trial currently recruiting people with noncolorectal gastrointestinal cancers.
  Medscape Medical News, April 07, 2023
• Why Are Scientists Getting Mice Drunk? Hint: They may have found a new way to help treat victims of alcohol poisoning.
  WebMD Health News, April 06, 2023
• Survival Improved for Some Patients With Metastatic Cancers Over the past 30 years, survival of patients with de novo metastatic cancers shows divergent trends, with substantial gains against some cancers but limited or no progress against others.
  Medscape Medical News, April 06, 2023
• More Data Needed for Neoadjuvant Tx for Bile Duct Cancer In a debate held recently on the use of neoadjuvant therapy for high-risk intrahepatic cholangiocarcinoma, both sides agreed that more research is needed.
  Medscape Medical News, April 05, 2023
• PNPLA3 Genotype, Diabetes Predict Cirrhosis in NAFLD Those with diabetes and indeterminate FIB4 scores may have the same risk of cirrhosis as patients with a high FIB4.
  MDedge News, April 04, 2023